Changeflow GovPing Pharma & Drug Safety USPTO Patent Application for Fusion Polypeptides
Routine Notice Added Final

USPTO Patent Application for Fusion Polypeptides

Favicon for changeflow.com ChangeBridge: Patent Apps - Peptides (C07K)
Published October 27th, 2023
Detected March 26th, 2026
Email

Summary

The USPTO has published a new patent application (US20260085300A1) detailing systems and compositions for fusion polypeptides and their methods of use in regulating target genes. The application was filed on October 27, 2023, by inventors Thomas Blair Gainous, Xiao Yang, Giovanni Carosso, Lei S. Qi, and Daniel O. Hart, II.

What changed

This document is a publication of a new patent application filed with the USPTO, specifically application US20260085300A1, titled "SYSTEMS AND COMPOSITIONS FOR FUSION POLYPEPTIDES AND METHODS OF USE THEREOF." The application describes polypeptide molecules designed to regulate target genes within cells. The filing date was October 27, 2023, and the application number is 19123019.

As this is a patent application publication, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in gene therapy or protein engineering, should be aware of this disclosure for potential intellectual property considerations and competitive intelligence. The abstract and CPC classifications provide technical details for those interested in the specific claims and scope of the invention.

Source document (simplified)

← USPTO Patent Applications

SYSTEMS AND COMPOSITIONS FOR FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

Application US20260085300A1 Kind: A1 Mar 26, 2026

Inventors

THOMAS BLAIR GAINOUS, XIAO YANG, GIOVANNI CAROSSO, LEI S. QI, DANIEL O. HART, II

Abstract

The present disclosure provides polypeptide molecules comprising one or more polypeptide chains and systems, compositions, and methods of use thereof, wherein the polypeptide molecule comprising one or more polypeptide chains (or engineered polypeptide chain) can be used to effect regulation of a target gene in a cell (e.g., an endogenous target gene in a cell).

CPC Classifications

C12N 9/226 C07K 14/4703 C07K 2319/00

Filing Date

2023-10-27

Application No.

19123019

View original document →

Named provisions

Abstract Filing Date Application No.

Classification

Agency
USPTO
Published
October 27th, 2023
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260085300A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Gene Regulation Biotechnology Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Peptides (C07K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.